menu
Even though these treatments are available, a significant unmet need exists for better treatment options for Ornithine Transcarbamylase (OTC) Deficiency Treatment.
Ornithine Transcarbamylase (OTC) Deficiency Treatment Market

OTC is a hereditary illness that is inherited and falls under the category of urea cycle disorders. Ammonia builds up in the blood as a result of the urea cycle being unable to function normally in Ornithine Transcarbamylase (OTC) Deficiency Treatment. Your body becomes poisonous when ammonia levels get too high. Elevated ammonia frequently has an adverse effect on the nervous system. The most frequent inherited urea cycle defect is known to be OTC. If there are abnormally high levels of ammonia in the blood, a blood test might reveal this. Some diseases may also exhibit high ammonia levels. As part of a full genetics workup, DNA genetic testing would be done to confirm a diagnosis of OTC.

 

Read More @ https://dailynewsmotion.weebly.com/blog/even-though-these-treatments-are-available-there-is-still-a-significant-unmet-need-for-better-treatments-for-ornithine-transcarbamylase-otc-deficiency-treatment

Facebook Conversations